J&J: Topamax Not Effective for Obesity, Diabetes

CHICAGO (Reuters) - Johnson & Johnson on Wednesday said its epilepsy drug Topamax was not effective as a treatment for obesity and diabetes.

Continue to J&J: Topamax Not Effective for Obesity, Diabetes on Reuters: Health.

Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz